nr507 week 1 discussions
Click Link Below To Buy:
Contact Us:
Hwcoursehelp@gmail.com
nr507 week 1 discussions
Week 1: Altered Immune System and Altered Inflammatory Response
– Discussion Part One
This week’s graded topics relate to the following Course Outcomes
(COs).
1 Analyze pathophysiologic mechanisms associated with selected
disease states. (PO 1)
2 Differentiate the epidemiology, etiology, developmental
considerations, pathogenesis, and clinical and laboratory manifestations of
specific disease processes. (PO
1)
3 Examine the way in which homeostatic, adaptive, and compensatory
physiological mechanisms can be supported and/or altered through specific
therapeutic interventions. (PO
1, 7)
6 Distinguish risk factors associated with selected disease states. (PO 1)
5 Describe outcomes of disruptive or alterations in specific
physiologic processes. (PO
1)
6 Distinguish risk factors associated with selected disease states. (PO 1)
7 Explore age-specific and developmental alterations in
physiologic
and disease states. (PO
1, 4)
Discussion
Discussion Part One (graded)
John is a 19-year-old college football player who presents with
sneezing, itchy eyes, and nasal congestion that worsens at night. He states that he has a history of
asthma, eczema and allergies
to pollen. There
is also one other person on the football team that has similar symptoms. His vitals are BP 110/70, P 84, R 18,
T 100 F. Write a differential of at least five
(5) possible items from the most likely to less likely. For each disease include information
about the epidemiology, pathophysiology and briefly argue why this disease fits
the presentation and why it might not fit the presentation
Week 1: Altered Immune System and Altered Inflammatory Response –
Discussion
Part Two
A patient has been admitted into the emergency room that was in
the passenger side of a car that collided with another car head on. The patient is pale, barely conscious
and has a weak and thready pulse. An
IV is started. The vitals are BP 80/50, P 140, T 96.0
and R 26. As the team fights to keep the patient
alive they have to remove the spleen. Blood
is given but it has been mistyped. A
transfusion reaction occurs. Describe
the type of hypersensitivity reaction that has occurred and discuss the
molecular pathophysiology of the specific type of hypersensitive reaction you
have chosen.
In the event that this patient survived the car accident and the
transfusion reaction which organs are most likely to be damaged and why?
Week 1: Altered Immune System and Altered Inflammatory
Response – Discussion Part Three
This week’s graded topics relate to the following Course Outcomes
(COs).
1 Analyze pathophysiologic mechanisms associated with selected
disease states. (PO 1)
2 Differentiate the epidemiology, etiology, developmental
considerations, pathogenesis, and clinical and laboratory manifestations of
specific disease processes. (PO
1)
3 Examine the way in which homeostatic, adaptive, and compensatory
physiological mechanisms can be supported and/or altered through specific
therapeutic interventions. (PO
1,
4 Distinguish risk factors associated with selected disease states.(PO
1)
5 Describe outcomes of disruptive or alterations in specific
physiologic processes. (PO
1)
6 Distinguish risk factors associated with selected disease states. (PO 1)
7 Explore age-specific and developmental alterations in
physiologic and disease states. (PO
1, 4)
Discussion
A 44-year-old patient presents with lump in the chest of
approximately 2 cm in diameter. There
is a slight dimple over the location of the lump and when the lump is
manipulated it seems to be attached to the surrounding tissue. A lumpectomy is performed and the mass
is sent to pathology. The
pathology report comes back and the mass is confirmed to be an estrogen
receptor negative, a progesterone receptor negative and a her2/neu receptor
positive breast cancer.
What are some of the risk factors for breast cancer?
What tumor suppressor genes are associated with breast cancer?
What tumor oncogenes are associated with breast cancer?
Compare and contrast tumor suppressor genes from oncogenes?
No comments:
Post a Comment